Telmisartan/Rosuvastatin 40/5 mg

Adult dose

Telmisartan: The recommended initial oral dose for adults with essential hypertension is 40 mg once daily, and 20 mg once daily may be effective for some patients. If necessary, the dose may be increased up to 80 mg once daily. For the purpose of reducing cardiovascular disease risk, a dose of 80 mg once daily is recommended. For patients with liver dysfunction, the dose should not exceed 40 mg once daily. Rosuvastatin Calcium: For adults with primary hypercholesterolemia, including mixed dyslipidemia (type IIa and type IIb), and primary dysbetalipoproteinemia (type III), patients should adhere to a standard cholesterol-lowering diet before and during treatment and continue it throughout the treatment period. This medication can be taken at any time of the day, with or without food. The initial dose is 5 mg once daily, and if more LDL cholesterol reduction is needed, the maintenance dose can be adjusted. The maintenance dose is usually 10 mg once daily, and most patients are managed on this dose. The maintenance dose should be adjusted based on LDL cholesterol levels, treatment targets, and patient response, with a maximum daily dose of 20 mg possible.

This medication can cause severe harm to the fetus and newborn if administered to pregnant women; therefore, it should be discontinued immediately upon confirmation of pregnancy. Patients with known allergies to this medication or its components, pregnant women or women of childbearing potential, and nursing mothers should not use this medication. Patients with severe liver dysfunction or those who have difficulty with bile excretion, myopathy, or severe renal impairment should avoid or use this medication with caution. Elderly patients, those with elevated potassium levels, and patients with slightly impaired liver function should use caution when taking this medication, and regular monitoring of liver function and muscle condition is necessary. This medication may cause myalgia, muscle weakness, and, in rare cases, severe muscle breakdown, so patients should consult a doctor immediately if symptoms such as muscle pain or weakness occur. This medication may interact with other drugs, so patients must inform their doctor or pharmacist of any medications they are currently taking. During the course of treatment with this medication, liver function tests and muscle-related tests should be performed regularly to detect any signs of abnormalities early. Care should be taken as dizziness or drowsiness may occur when driving or operating machinery. Keep this medication in a safe place out of reach of children, and it is advisable not to transfer it to another container.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, pain in oral/ocular mucosa, shortness of breath or difficulty breathing, asthma attacks, cough with fever-related respiratory issues, jaundice (yellowing of the skin or eyes), profound lethargy, sudden severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, and urinary issues.

Mild side effects

• Headache
• orthostatic dizziness
• sleepiness
• elevated blood pressure
• decreased diastolic blood pressure
• hypotension
• elevated ALT
• dysuria
• rhinitis
• discomfort in the oropharynx

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is recommended to maintain storage temperatures between 1°C and 30°C at room temperature.

Appearance

Bright pink oval film-coated tablet

Package unit

30 tablets/box [10 tablets/PTP*3]